EPO-patent

  • 15:14

Immunicum AB (publ) today announced that the European Patent Office (EPO) has announced its intention to grant a patent pertaining to the production method of the Company’s therapeutic cancer vaccines.

Read the press release here: Press release 150127 – patent EPO